🕵️ PHIO Pharmaceuticals Corp. ($PHIO)
SEC insider & ownership activity, last 12 months · CIK 1533040 · every row links its SEC filing
Over the last 12 months insiders bought $32K with no open-market selling against it. Robert J. Bitterman bought $32K (Nov–Jun). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $32K (5 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Robert J. Bitterman | 5 | $32K | 0 | – | Jun 26, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| CVI Investments, Inc. | 9.9% | 13G | Feb 17, 2026 | filing ↗ | |
| Heights Capital Management, Inc. | 9.9% | 13G | Feb 17, 2026 | filing ↗ | |
| Mitchell P. Kopin | 9.1% | 13G | Feb 13, 2026 | filing ↗ | |
| Daniel B. Asher | 9.1% | 13G | Feb 13, 2026 | filing ↗ | |
| Intracoastal Capital LLC | 9.1% | 13G | Feb 13, 2026 | filing ↗ | |
| CVI Investments, Inc. | 7.3% | 13G | Dec 26, 2024 | filing ↗ | |
| Heights Capital Management, Inc. | 7.3% | 13G | Dec 26, 2024 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | Jul 21, 2026 | filing ↗ |
| Other events (8.01) | Jul 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 21, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 8, 2026 | filing ↗ |
| Other events (8.01) | Mar 30, 2026 | filing ↗ |
| Earnings (2.02) | Mar 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 5, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 17, 2026 | filing ↗ |
| Other events (8.01) | Feb 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 10, 2026 | filing ↗ |
| Other events (8.01) | Jan 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 20, 2026 | filing ↗ |
| Other events (8.01) | Dec 23, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 23, 2025 | filing ↗ |
| Other events (8.01) | Nov 25, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 25, 2025 | filing ↗ |
| Earnings (2.02) | Nov 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 13, 2025 | filing ↗ |
| Material agreement (1.01) | Nov 3, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Nov 3, 2025 | filing ↗ |
| Other events (8.01) | Nov 3, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 3, 2025 | filing ↗ |
| Other events (8.01) | Nov 3, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 3, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 31, 2025 | filing ↗ |
| Other events (8.01) | Oct 31, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 31, 2025 | filing ↗ |